Targeting DNA methylation, ROS, MAPK, and AP-1 mitigates leukemogenesis associated with asxl1 and IDH2R172K comutation associated with asxl1 and IDH2R172K comutations in zebrafish.
Abstract
Key Points • asxl1 and IDH2R172K comutation epigenetically silences tet2 and activates the MAPK and AP-1 pathways in leukemia.• Targeting DNA methylation, ROS, MAPK, and AP-1 mitigates leukemogenesis associated with asxl1 and IDH2R172K comutations in zebrafish.
Highlights • SENP7 protein is markedly expressed in LUAD, with a strong correlation to disease progression and adverse patient prognoses.• The depletion of SENP7 substantially impedes LUAD progression in both in vitro and in vivo.• SP1 is a bona fide target of SENP7, with SENP7-mediated deSUMOylation, deubiquitination,...
Highlights • Genetically proxied RAF1 and MAPK8 expression was associated with pancreatic cancer risk.• A circulating CD4+ Treg-related phenotype showed a possible partial indirect contribution.• PheWAS detected no broad genetic pleiotropic signals at the prespecified threshold.• The findings support further study of R...
Feng-Chang Lin, Wen-Wen Tu, Rong-Gui Lin et al.· Translational Oncology· 0 citations
SH2B1 encodes an adaptor protein involved in metabolic regulation and body‐weight control. Although SH2B1 haploinsufficiency is a recognized contributor to obesity in 16p11.2 deletion syndrome, the relationship between rare monoallelic SH2B1 variants and neurodevelopmental disorders (NDDs) remains poorly characterized.
Simple Summary Epigenetic alterations accumulate throughout life in hematopoietic stem and progenitor cells (HSPCs), leading to an increased risk of acute myeloid leukaemia (AML). Here, we investigated whether targeting the methylation of histone 3 at lysine 9 (H3K9 methylation) affects HSPCs upon aging and leukemogene...
Barbara Walter, P. Zjablovskaja, Sara Montserrat-Vazquez et al.· Cancers· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.